Nurse Practitioner · La Jolla, CA
NPI
1154467975
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10666 N Torrey Pines Rd
La Jolla, CA, 92037
Phone (858) 554-8203
Groups this clinician bills Medicare through
Medicare paid, 2024
$154K
3,140 services
Medicare patients, 2024
376
Average age 76
Drug cost, 2024
$3.8M
3,930 prescriptions
Company payments, 2025
$63K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherrie E Gould was code 99215 (office e&m - established), 927 times for 362 patients. In total Sherrie E Gould billed 3,140 services in 11 codes, and Medicare paid $154K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 927 | 362 | $118.38 | $110K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 844 | 344 | $11.00 | $9,281 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 656 | 297 | $21.63 | $14K |
| 95984 Electrical Nerve Conductivity | Office | 325 | 62 | $28.24 | $9,178 |
| 95983 Electrical Nerve Conductivity | Office | 164 | 62 | $33.64 | $5,517 |
| 11105 Skin Biopsy | Office | 40 | 20 | $44.18 | $1,767 |
| 11104 Skin Biopsy | Office | 20 | 20 | $93.42 | $1,868 |
By year: 2022 $130K for 1,689 services; 2023 $132K for 1,924 services; 2024 $154K for 3,140 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherrie E Gould prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 689 prescriptions and refills. In total Sherrie E Gould wrote 3,930 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rytary Carbidopa/Levodopa | 689 | 1,446 | 151 | $831K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 628 | 1,588 | 189 | $28K |
| Nuplazid Pimavanserin Tartrate | 307 | 429 | 53 | $2.1M |
| Rasagiline Mesylate Generic | 175 | 479 | 55 | $43K |
| Clonazepam Generic | 163 | 298 | 53 | $1,600 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 146 | 368 | 44 | $14K |
| Donepezil Hcl Generic | 115 | 240 | 26 | $1,205 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 109 | 287 | 36 | $3,841 |
| Gocovri Amantadine Hcl | 87 | 127 | 14 | $337K |
| Primidone Generic | 86 | 180 | 24 | $2,538 |
| Escitalopram Oxalate Generic | 84 | 195 | 24 | $1,617 |
| Ongentys Opicapone | 84 | 181 | 26 | $117K |
| Propranolol Hcl Er Propranolol Hcl | 81 | 163 | 18 | $3,469 |
| Trazodone Hcl Generic | 80 | 152 | 17 | $626 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 72 | 152 | 21 | $26K |
Brand drugs: 1,424 claims; generic drugs: 2,506 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sherrie E Gould $63K ($63K in general payments such as food, travel and fees) from 17 companies. The largest payer was ACADIA Pharmaceuticals Inc with $31K.
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc ACAD | 80 | $31K |
| Merz Pharmaceuticals, LLC | 20 | $7,652 |
| MDD US Operations, LLC | 32 | $5,767 |
| Amneal Pharmaceuticals LLC AMRX | 15 | $5,381 |
| Boston Scientific Corporation BSX | 16 | $5,284 |
| Medtronic, Inc. MDT | 27 | $3,028 |
| Tanabe Pharma America, Inc. | 6 | $2,760 |
| Abbvie Inc. ABBV | 20 | $775 |
| Abbott Laboratories ABT | 5 | $501 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $202 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.